Clinical Trial Update: Safety and Efficacy of Injection of Human Placenta Mesenchymal Stem Cells Derived Exosomes for Treatment of Complex Anal Fistula [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating safety and efficacy of injections of exosomes derived from human placenta mesenchymal stem cells for treatment of perianal fistula.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fistula Perianal

Drugs mentioned

• Human placenta mesenchymal stem cell-derived exosomes

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Fistula Perianal | Phase 1, Phase 2 | Status: UNKNOWN